Philip E. Hass

Person

South San Francisco, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Tie2-binding agents and methods of use
- Patent number 11,999,787
- Issue date Jun 4, 2024
- Genentech, Inc.
- Minhong Yan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-interleukin-33 antibodies and uses thereof
- Patent number 11,725,050
- Issue date Aug 15, 2023
- Genentech, Inc.
- Philip E. Hass
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
IL-22 Fc fusion proteins
- Patent number 11,332,507
- Issue date May 17, 2022
- Genentech, Inc.
- Justin Scheer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating acute pancreatitis using IL-22 fc fusion proteins
- Patent number 11,155,591
- Issue date Oct 26, 2021
- Genentech, Inc.
- Justin Scheer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods for preventing or treating cardiovascular conditions using...
- Patent number 11,136,365
- Issue date Oct 5, 2021
- Genentech, Inc.
- Justin Scheer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for treating metabolic syndrome using IL-22 Fc fusion proteins
- Patent number 11,130,791
- Issue date Sep 28, 2021
- Genentech, Inc.
- Justin Scheer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-factor D antibody variant conjugates and uses thereof
- Patent number 10,961,313
- Issue date Mar 30, 2021
- Genentech, Inc.
- Philip E. Hass
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-interleukin-33 antibodies and uses thereof
- Patent number 10,723,795
- Issue date Jul 28, 2020
- Genentech, Inc.
- Philip E. Hass
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-factor D antibody variant conjugates and uses thereof
- Patent number 10,654,932
- Issue date May 19, 2020
- Genentech, Inc.
- Philip E. Hass
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pharmaceutical compositions of IL-22 Fc fusion proteins
- Patent number 10,584,155
- Issue date Mar 10, 2020
- Genentech, Inc.
- Justin Scheer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of accelerating or improving wound healing using IL-22 FC f...
- Patent number 10,544,198
- Issue date Jan 28, 2020
- Genentech, Inc.
- Justin Scheer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-factor D antibodies
- Patent number 10,179,821
- Issue date Jan 15, 2019
- Genentech, Inc.
- Robert F Kelley
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of treating inflammatory bowel disease using IL-22 Fc fusio...
- Patent number 10,160,793
- Issue date Dec 25, 2018
- Genentech, Inc.
- Justin Scheer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-interleukin-33 antibodies and uses thereof
- Patent number 10,093,730
- Issue date Oct 9, 2018
- Genentech, Inc.
- Philip E. Hass
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Nucleic acids encoding IL-22 Fc fusion proteins
- Patent number 10,087,227
- Issue date Oct 2, 2018
- Genentech, Inc.
- Justin Scheer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies directed to IL-17A/IL-17F heterodimers
- Patent number 10,011,654
- Issue date Jul 3, 2018
- Genentech, Inc.
- David P. Arnott
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
IL-22 Fc fusion proteins
- Patent number 9,815,880
- Issue date Nov 14, 2017
- Genentech, Inc.
- Justin Scheer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Prevention and treatment of complement-associated eye conditions
- Patent number 8,497,094
- Issue date Jul 30, 2013
- Genentech, Inc.
- Philip Hass
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Prevention and treatment of complement-associated eye conditions
- Patent number 8,268,310
- Issue date Sep 18, 2012
- Genentech, Inc.
- Philip Hass
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Prevention and treatment of complement-associated eye conditions
- Patent number 8,007,791
- Issue date Aug 30, 2011
- Genentech, Inc.
- Philip Hass
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystal structure of CRIg and C3b:CRIg complex
- Patent number 7,930,109
- Issue date Apr 19, 2011
- Genentech, Inc.
- Philip Hass
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystal structure of CRIg and C3b:CRIg complex
- Patent number 7,776,573
- Issue date Aug 17, 2010
- Genentech, Inc.
- Philip Hass
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of treating coagulapathic or thrombotic disorders
- Patent number 7,354,585
- Issue date Apr 8, 2008
- Genentech, Inc.
- Camellia W. Adams
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Human anti-factor IX/IXa antibodies
- Patent number 7,049,411
- Issue date May 23, 2006
- Genentech, Inc.
- Camellia W. Adams
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Human anti-factor IX/IXa antibodies
- Patent number 6,624,295
- Issue date Sep 23, 2003
- Genentech, Inc.
- Camellia W. Adams
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
TIE2-BINDING AGENTS AND METHODS OF USE
- Publication number 20240327528
- Publication date Oct 3, 2024
- Genentech, Inc.
- Minhong YAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE
- Publication number 20230063741
- Publication date Mar 2, 2023
- Genentech, Inc.
- Justin SCHEER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IL-17A/F HETEROLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF
- Publication number 20220213184
- Publication date Jul 7, 2022
- Novartis Pharma AG
- David P Arnott
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IL-17A/F HETEROLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF
- Publication number 20220213183
- Publication date Jul 7, 2022
- Novartis Pharma AG
- David P Arnott
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IL-17A/F HETEROLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF
- Publication number 20220204606
- Publication date Jun 30, 2022
- Novartis Pharma AG
- David P Arnott
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TIE2-BINDING AGENTS AND METHODS OF USE
- Publication number 20210332142
- Publication date Oct 28, 2021
- Genentech, Inc.
- Minhong YAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-INTERLEUKIN-33 ANTIBODIES AND USES THEREOF
- Publication number 20210002361
- Publication date Jan 7, 2021
- Genentech, Inc.
- Philip E. HASS
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
IL-17A/F HETEROLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF
- Publication number 20200385452
- Publication date Dec 10, 2020
- Genentech, Inc.
- David P. Arnott
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IL-17A/F HETEROLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF
- Publication number 20200377585
- Publication date Dec 3, 2020
- Genentech, Inc.
- David P. ARNOTT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IL-17A/F HETEROLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF
- Publication number 20200377584
- Publication date Dec 3, 2020
- David P. ARNOTT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-FACTOR D ANTIBODY VARIANT CONJUGATES AND USES THEREOF
- Publication number 20200115462
- Publication date Apr 16, 2020
- Genentech, Inc.
- Philip E. Hass
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE
- Publication number 20190233491
- Publication date Aug 1, 2019
- Genentech, Inc.
- Justin SCHEER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE
- Publication number 20190177386
- Publication date Jun 13, 2019
- Genentech, Inc.
- Justin SCHEER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE
- Publication number 20190177388
- Publication date Jun 13, 2019
- Genentech, Inc.
- Justin SCHEER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE
- Publication number 20190177390
- Publication date Jun 13, 2019
- Genentech, Inc.
- Justin SCHEER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE
- Publication number 20190177389
- Publication date Jun 13, 2019
- Genentech, Inc.
- Justin SCHEER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE
- Publication number 20190177387
- Publication date Jun 13, 2019
- Genentech, Inc.
- Justin SCHEER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IL-17A/F HETEROLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF
- Publication number 20190100583
- Publication date Apr 4, 2019
- Genentech, Inc.
- David P. ARNOTT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-INTERLEUKIN-33 ANTIBODIES AND USES THEREOF
- Publication number 20190092852
- Publication date Mar 28, 2019
- Genentech, Inc.
- Philip E. HASS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE
- Publication number 20180362608
- Publication date Dec 20, 2018
- Genentech, Inc.
- Justin SCHEER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IL-22 Fc FUSION PROTEIN AND METHODS OF USE
- Publication number 20180355009
- Publication date Dec 13, 2018
- Genentech, Inc.
- Justin SCHEER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PREVENTION AND TREATMENT OF COMPLEMENT-ASSOCIATED EYE CONDITIONS
- Publication number 20180079826
- Publication date Mar 22, 2018
- Genentech, Inc.
- Philip Hass
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE
- Publication number 20170320926
- Publication date Nov 9, 2017
- Genentech, Inc.
- JUSTIN SCHEER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IL-17A/F HETEROLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF
- Publication number 20170291940
- Publication date Oct 12, 2017
- Genentech, Inc.
- David P. ARNOTT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-FACTOR D ANTIBODY VARIANT CONJUGATES AND USES THEREOF
- Publication number 20170143843
- Publication date May 25, 2017
- Genentech, Inc.
- Philip E. Hass
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE
- Publication number 20170088596
- Publication date Mar 30, 2017
- Genentech, Inc.
- Justin SCHEER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IL-17A/F HETEROLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF
- Publication number 20170073409
- Publication date Mar 16, 2017
- Genentech, Inc.
- David P. ARNOTT
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE
- Publication number 20170008942
- Publication date Jan 12, 2017
- Genentech, Inc.
- JUSTIN SCHEER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PREVENTION AND TREATMENT OF COMPLEMENT-ASSOCIATED EYE CONDITIONS
- Publication number 20160272726
- Publication date Sep 22, 2016
- Genentech, Inc.
- Philip HASS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-INTERLEUKIN-33 ANTIBODIES AND USES THEREOF
- Publication number 20160168242
- Publication date Jun 16, 2016
- Genentech, Inc.
- Philip E. HASS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Philip E. Hass

Person

Patents Grantslast 30 patents

Tie2-binding agents and methods of use

Anti-interleukin-33 antibodies and uses thereof

IL-22 Fc fusion proteins

Methods of treating acute pancreatitis using IL-22 fc fusion proteins

Methods for preventing or treating cardiovascular conditions using...

Methods for treating metabolic syndrome using IL-22 Fc fusion proteins

Anti-factor D antibody variant conjugates and uses thereof

Anti-interleukin-33 antibodies and uses thereof

Anti-factor D antibody variant conjugates and uses thereof

Pharmaceutical compositions of IL-22 Fc fusion proteins

Methods of accelerating or improving wound healing using IL-22 FC f...

Anti-factor D antibodies

Methods of treating inflammatory bowel disease using IL-22 Fc fusio...

Anti-interleukin-33 antibodies and uses thereof

Nucleic acids encoding IL-22 Fc fusion proteins

Antibodies directed to IL-17A/IL-17F heterodimers

IL-22 Fc fusion proteins

Prevention and treatment of complement-associated eye conditions

Prevention and treatment of complement-associated eye conditions

Prevention and treatment of complement-associated eye conditions

Crystal structure of CRIg and C3b:CRIg complex

Crystal structure of CRIg and C3b:CRIg complex

Methods of treating coagulapathic or thrombotic disorders

Human anti-factor IX/IXa antibodies

Human anti-factor IX/IXa antibodies

Patents Applicationslast 30 patents

TIE2-BINDING AGENTS AND METHODS OF USE

IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE

IL-17A/F HETEROLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF

IL-17A/F HETEROLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF

IL-17A/F HETEROLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF

TIE2-BINDING AGENTS AND METHODS OF USE

ANTI-INTERLEUKIN-33 ANTIBODIES AND USES THEREOF

IL-17A/F HETEROLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF

IL-17A/F HETEROLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF

IL-17A/F HETEROLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF

ANTI-FACTOR D ANTIBODY VARIANT CONJUGATES AND USES THEREOF

IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE

IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE

IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE

IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE

IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE

IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE

IL-17A/F HETEROLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF

ANTI-INTERLEUKIN-33 ANTIBODIES AND USES THEREOF

IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE

IL-22 Fc FUSION PROTEIN AND METHODS OF USE

PREVENTION AND TREATMENT OF COMPLEMENT-ASSOCIATED EYE CONDITIONS

IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE

IL-17A/F HETEROLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF

ANTI-FACTOR D ANTIBODY VARIANT CONJUGATES AND USES THEREOF

IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE

IL-17A/F HETEROLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF

IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE

PREVENTION AND TREATMENT OF COMPLEMENT-ASSOCIATED EYE CONDITIONS

ANTI-INTERLEUKIN-33 ANTIBODIES AND USES THEREOF